Effects of topiramate on diabetes mellitus induced by streptozotocin in rats
- 1 June 2012
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 684 (1-3) , 161-167
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trialInternational Journal of Obesity, 2007
- Topiramate and its clinical applications in epilepsyExpert Opinion on Pharmacotherapy, 2006
- Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- The Mechanism of Neuroprotection by Topiramate in an Animal Model of EpilepsyEpilepsia, 2004
- Topiramate ameliorates hyperglycaemia and improves glucose‐stimulated insulin release in ZDF rats and db/db miceDiabetes, Obesity and Metabolism, 2004
- Glutamate-mediated signaling in the islets of Langerhans: a thread entangledTrends in Pharmacological Sciences, 2003
- Differentiation-associated Na+-dependent Inorganic Phosphate Cotransporter (DNPI) Is a Vesicular Glutamate Transporter in Endocrine Glutamatergic SystemsJournal of Biological Chemistry, 2001
- Mitochondria and calcium: from cell signalling to cell deathThe Journal of Physiology, 2000
- TopiramateClinical Pharmacokinetics, 1998
- Regulation of ob gene mRNA levels in cultured adipocytesFEBS Letters, 1996